Innophos Holdings (NASDAQ: IPHS) is one of 35 public companies in the “Commodity Chemicals” industry, but how does it weigh in compared to its competitors? We will compare Innophos Holdings to similar businesses based on the strength of its valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and profitability.


Innophos Holdings pays an annual dividend of $1.92 per share and has a dividend yield of 4.2%. Innophos Holdings pays out 88.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. As a group, “Commodity Chemicals” companies pay a dividend yield of 1.8% and pay out 38.0% of their earnings in the form of a dividend.

Insider and Institutional Ownership

94.4% of Innophos Holdings shares are owned by institutional investors. Comparatively, 69.2% of shares of all “Commodity Chemicals” companies are owned by institutional investors. 2.3% of Innophos Holdings shares are owned by company insiders. Comparatively, 8.2% of shares of all “Commodity Chemicals” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.


This table compares Innophos Holdings and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Innophos Holdings 6.19% 13.90% 7.26%
Innophos Holdings Competitors -23.28% 24.51% 5.87%

Earnings & Valuation

This table compares Innophos Holdings and its competitors revenue, earnings per share and valuation.

Gross Revenue NetIncome Price/Earnings Ratio
Innophos Holdings $725.34 $47.97 21.22
Innophos Holdings Competitors $4,143.88 $352.97 33.25

Innophos Holdings’ competitors have higher revenue and earnings than Innophos Holdings. Innophos Holdings is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Innophos Holdings and its competitors, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Innophos Holdings 0 1 1 0 2.50
Innophos Holdings Competitors 104 793 1175 34 2.54

Innophos Holdings currently has a consensus price target of $56.00, indicating a potential upside of 21.63%. As a group, “Commodity Chemicals” companies have a potential downside of 7.00%. Given Innophos Holdings’ higher possible upside, equities analysts clearly believe Innophos Holdings is more favorable than its competitors.

Volatility and Risk

Innophos Holdings has a beta of 0.88, indicating that its stock price is 12% less volatile than the S&P 500. Comparatively, Innophos Holdings’ competitors have a beta of 1.20, indicating that their average stock price is 20% more volatile than the S&P 500.


Innophos Holdings competitors beat Innophos Holdings on 10 of the 15 factors compared.

About Innophos Holdings

Innophos Holdings, Inc. is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other. The Company has four principal product lines: Specialty Ingredients; Food and Technical Grade Purified Phosphoric Acid (PPA); Technical Grade Sodium Tripolyphosphate (STPP), & Detergent Grade PPA, and GTSP & Other. The Company’s bioactive mineral ingredients are mineral-based ingredients for food, beverage and dietary supplement end markets that are manufactured to be readily digestible. The Company has its manufacturing facilities located throughout the United States, Canada, Mexico and China.

Receive News & Ratings for Innophos Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos Holdings Inc. and related companies with's FREE daily email newsletter.